PF-04856884

· Pfizer

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for PF-04856884, covering 2015-03-11 to 2016-01-18. Get the full timeline:

Most recent: Clinical Trial Update: PF-04856884 (CVX-060) In Combination With Axitinib In Patients With Previously Treated Metastatic Renal Cell Carcinoma [Phase 2]

See pricing